PATENT CLAIM ANALYSIS

Application Number: 15767086
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["424", "204100"]

Abstract:
This invention presents the method and use of the AAV-XBP1s/GFP virus, in the prevention and treatment of amyotrophic lateral sclerosis, as presented in the in vivo studies in FIG.  6.

Claim (Index 54):
A method of preventing, treating and/or delaying amyotrophic lateral sclerosis (ALS) in a mammal suffering therefrom, the method comprising administering to the mammal a therapeutically effective amount of a vector that induces neuronal overexpression of X-Box protein 1 (XBP1) in the central nervous system (CNS) of the mammal, wherein the vector is an adeno-associated virus (AAV) vector.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 97.0
- Lexical Diversity: 1.41667
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15327011', '12328267', '12417910', '15126688', '14445670']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6562897733349622
- 35 USC 102 Novelty (BERT): 0.5159831468218471
- Combined Prediction Score: 0.6422591106836507
- Mean Citation Score: 263.60930399999995
- Max Citation Score: 288.1689
- Similarity Product: 214.01321168943645

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test